{"name": "Vertex Pharmaceuticals",
 "permalink": "vertex-pharmaceuticals",
 "crunchbase_url": "http://www.crunchbase.com/company/vertex-pharmaceuticals",
 "homepage_url": "http://www.vrtx.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "VertexPharma",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 1989,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "44-(0)-1235-438-800",
 "description": "Viral Disease Treatment Research",
 "created_at": "Mon Oct 12 05:58:27 UTC 2009",
 "updated_at": "Tue Apr 09 03:00:13 UTC 2013",
 "overview": "\u003Cp\u003EVertex Pharmaceuticals Incorporated is a global biotechnology company committed to the discovery and development of breakthrough small molecule drugs for serious diseases. The Company\u0026#8217;s strategy is to commercialize its products both independently and in collaboration with major pharmaceutical companies. Vertex\u0026#8217;s product pipeline is focused on viral diseases, cystic fibrosis, inflammation, autoimmune diseases, cancer, and pain\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[121,
       75],
      "assets/images/resized/0006/2433/62433v1-max-150x150.jpg"],
     [[121,
       75],
      "assets/images/resized/0006/2433/62433v1-max-250x250.jpg"],
     [[121,
       75],
      "assets/images/resized/0006/2433/62433v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO-designate",
    "person":
     {"first_name": "Jeffrey",
      "last_name": "Leiden",
      "permalink": "jeffrey-leiden",
      "image": null}},
   {"is_past": false,
    "title": "Chairman, President and CEO",
    "person":
     {"first_name": "Matthew",
      "last_name": "W. Emmens",
      "permalink": "matthew-w-emmens",
      "image": null}},
   {"is_past": false,
    "title": "Co-Founder",
    "person":
     {"first_name": "Larry",
      "last_name": "Bock",
      "permalink": "larry-bock",
      "image":
       {"available_sizes":
         [[[110,
            150],
           "assets/images/resized/0009/9950/99950v1-max-150x150.jpg"],
          [[183,
            250],
           "assets/images/resized/0009/9950/99950v1-max-250x250.jpg"],
          [[330,
            450],
           "assets/images/resized/0009/9950/99950v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Executive Vice President \u0026 CFO",
    "person":
     {"first_name": "Ian",
      "last_name": "F. Smith",
      "permalink": "ian-f-smith",
      "image": null}},
   {"is_past": false,
    "title": "Sr Scientific associate",
    "person":
     {"first_name": "Dhaval",
      "last_name": "Rathod",
      "permalink": "dhaval-rathod",
      "image": null}},
   {"is_past": true,
    "title": "Chief Commercial Officer \u0026 Head of Corporate \u0026 Strategic Drug Development",
    "person":
     {"first_name": "Kurt",
      "last_name": "Graves",
      "permalink": "kurt-graves",
      "image": null}},
   {"is_past": true,
    "title": "Chief Scientific Officer",
    "person":
     {"first_name": "Vicki",
      "last_name": "L. Sato",
      "permalink": "vicki-l-sato",
      "image":
       {"available_sizes":
         [[[126,
            150],
           "assets/images/resized/0026/7595/267595v1-max-150x150.jpg"],
          [[130,
            154],
           "assets/images/resized/0026/7595/267595v1-max-250x250.jpg"],
          [[130,
            154],
           "assets/images/resized/0026/7595/267595v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": true,
    "title": "President",
    "person":
     {"first_name": "Vicki",
      "last_name": "L. Sato",
      "permalink": "vicki-l-sato",
      "image":
       {"available_sizes":
         [[[126,
            150],
           "assets/images/resized/0026/7595/267595v1-max-150x150.jpg"],
          [[130,
            154],
           "assets/images/resized/0026/7595/267595v1-max-250x250.jpg"],
          [[130,
            154],
           "assets/images/resized/0026/7595/267595v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": true,
    "title": "CTO \u0026 Chair of the Scientific Advisory Board",
    "person":
     {"first_name": "Mark",
      "last_name": "Murcko",
      "permalink": "mark-murcko",
      "image":
       {"available_sizes":
         [[[150,
            135],
           "assets/images/resized/0027/4281/274281v1-max-150x150.jpg"],
          [[250,
            225],
           "assets/images/resized/0027/4281/274281v1-max-250x250.jpg"],
          [[450,
            405],
           "assets/images/resized/0027/4281/274281v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": true,
    "title": "Director, Regulatory Affairs",
    "person":
     {"first_name": "Eric",
      "last_name": "Ruby",
      "permalink": "eric-ruby",
      "image": null}},
   {"is_past": true,
    "title": "Head of Marketing",
    "person":
     {"first_name": "Bart",
      "last_name": "Henderson",
      "permalink": "bart-henderson",
      "image": null}},
   {"is_past": true,
    "title": "Sr. Director, Regulatory Affairs",
    "person":
     {"first_name": "Eric",
      "last_name": "Ruby",
      "permalink": "eric-ruby",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$598M",
 "funding_rounds":
  [{"round_code": "post_ipo_equity",
    "source_url": "http://investors.vrtx.com/releasedetail.cfm?ReleaseID=412838",
    "source_description": "Vertex Pharmaceuticals to Receive $155 Million in Cash Related to Future Telaprevir Milestone Payments",
    "raised_amount": 35000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2009,
    "funded_month": 9,
    "funded_day": 30,
    "investments":
     []},
   {"round_code": "post_ipo_equity",
    "source_url": "http://www.fiercebiotech.com/story/vertex-adds-443m-its-big-cash-stash/2009-12-03?utm_medium=rss\u0026utm_source=rss\u0026cmp-id=OTC-RSS-FB0",
    "source_description": "Vertex adds $443M to its big cash stash",
    "raised_amount": 443000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2009,
    "funded_month": 12,
    "funded_day": 3,
    "investments":
     []},
   {"round_code": "post_ipo_debt",
    "source_url": "http://investors.vrtx.com/releasedetail.cfm?ReleaseID=412838",
    "source_description": "Vertex Pharmaceuticals to Receive $155 Million in Cash Related to Future Telaprevir Milestone Payments",
    "raised_amount": 120000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2009,
    "funded_month": 9,
    "funded_day": 30,
    "investments":
     []}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "88 Milton Park, Abingdon",
    "address2": "",
    "zip_code": "OX14 4RY",
    "city": "Oxfordshire",
    "state_code": null,
    "country_code": "GBR",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [{"description": "Vertex Pharmaceuticals Inc. said it plans to raise funds by selling $375 million worth of senior subordinated notes due 2015.",
    "stoned_year": 2010,
    "stoned_month": 9,
    "stoned_day": 23,
    "source_url": "http://www.masshightech.com/stories/2010/09/20/daily41-Vertex-Pharmaceuticals-raising-375M-in-notes-sale.html",
    "source_text": null,
    "source_description": "Vertex Pharmaceuticals raising $375M in notes sale",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Vertex Pharmaceuticals",
      "permalink": "vertex-pharmaceuticals"}},
   {"description": "has begun a Phase 2a clinical trial of a cystic fibrosis treatment that combines two of the company\u00e2\u20ac\u2122s regimens",
    "stoned_year": 2010,
    "stoned_month": 10,
    "stoned_day": 18,
    "source_url": "http://www.masshightech.com/stories/2010/10/18/daily12-Vertex-cystic-fibrosis-treatment-trial-begins.html",
    "source_text": null,
    "source_description": "Vertex cystic fibrosis treatment trial begins",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Vertex Pharmaceuticals",
      "permalink": "vertex-pharmaceuticals"}},
   {"description": "has won priority review from the U.S. Food and Drug Administration for its hepatitis C virus treatment, telaprevir",
    "stoned_year": 2011,
    "stoned_month": 1,
    "stoned_day": 20,
    "source_url": "http://www.masshightech.com/stories/2011/01/17/daily36-Vertex-hepatitis-C-drug-wins-FDA-priority-review.html",
    "source_text": null,
    "source_description": "Vertex hepatitis C drug wins FDA priority review",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Vertex Pharmaceuticals",
      "permalink": "vertex-pharmaceuticals"}},
   {"description": "plans to move to Fan Pier on the South Boston waterfront",
    "stoned_year": 2011,
    "stoned_month": 1,
    "stoned_day": 24,
    "source_url": "http://www.masshightech.com/stories/2011/01/24/daily11-Vertex-moving-to-Bostons-Fan-Pier.html",
    "source_text": null,
    "source_description": "Vertex moving to Boston's Fan Pier",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Vertex Pharmaceuticals",
      "permalink": "vertex-pharmaceuticals"}},
   {"description": "Vertex forms $75M deal with CFF",
    "stoned_year": 2011,
    "stoned_month": 4,
    "stoned_day": 7,
    "source_url": "http://www.masshightech.com/stories/2011/04/04/daily45-Vertex-forms-75M-deal-with-CFF.html",
    "source_text": "",
    "source_description": "Vertex forms $75M deal with CFF",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Vertex Pharmaceuticals",
      "permalink": "vertex-pharmaceuticals"}},
   {"description": "signed a lease to move to Fan Pier on the South Boston waterfront, from Cambridge",
    "stoned_year": 2011,
    "stoned_month": 5,
    "stoned_day": 5,
    "source_url": "http://www.masshightech.com/stories/2011/05/02/daily47-Vertex-signs-lease-for-South-Boston-move.html",
    "source_text": null,
    "source_description": "Vertex signs lease for South Boston move",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Vertex Pharmaceuticals",
      "permalink": "vertex-pharmaceuticals"}},
   {"description": "has won approval from the U.S. Food and Drug Administration for its hepatitis C drug, Incivek.",
    "stoned_year": 2011,
    "stoned_month": 5,
    "stoned_day": 23,
    "source_url": "http://www.masshightech.com/stories/2011/05/23/daily4-Vertex-hepatitis-C-drug-gets-FDA-OK.html",
    "source_text": null,
    "source_description": "Vertex hepatitis C drug gets FDA OK",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Vertex Pharmaceuticals",
      "permalink": "vertex-pharmaceuticals"}},
   {"description": "Vertex awards $1.5M to help Hepatitis C patients",
    "stoned_year": 2011,
    "stoned_month": 11,
    "stoned_day": 4,
    "source_url": "http://www.masshightech.com/stories/2011/10/31/daily57-Vertex-awards-15M-to-help-Hepatitis-C-patients.html",
    "source_text": "",
    "source_description": "Vertex awards $1.5M to help Hepatitis C patients",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Vertex Pharmaceuticals",
      "permalink": "vertex-pharmaceuticals"}}],
 "ipo":
  {"valuation_amount": null,
   "valuation_currency_code": "USD",
   "pub_year": 1991,
   "pub_month": 8,
   "pub_day": 2,
   "stock_symbol": "NASDAQ:VRTX"},
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        88],
       "assets/images/resized/0006/2434/62434v1-max-150x150.jpg"],
      [[250,
        148],
       "assets/images/resized/0006/2434/62434v1-max-250x250.jpg"],
      [[450,
        266],
       "assets/images/resized/0006/2434/62434v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}